CREDIT SUISSE AG/ - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$87,054,000
+30.5%
3,745,892
-10.6%
0.09%
+38.7%
Q1 2018$66,696,000
+37.8%
4,189,370
+79.9%
0.06%
+44.2%
Q4 2017$48,392,000
+80.4%
2,328,795
+24.4%
0.04%
+65.4%
Q3 2017$26,821,000
+20.0%
1,871,580
+44.9%
0.03%
+23.8%
Q2 2017$22,351,000
+91.4%
1,291,950
+22.0%
0.02%
+90.9%
Q1 2017$11,680,000
-49.3%
1,058,955
-33.3%
0.01%
-52.2%
Q4 2016$23,053,000
-26.3%
1,587,687
+24.6%
0.02%
-23.3%
Q3 2016$31,284,000
+30.4%
1,274,230
+6.9%
0.03%
+11.1%
Q2 2016$23,997,000
+8.0%
1,191,519
+41.0%
0.03%0.0%
Q1 2016$22,228,000
-85.8%
845,132
-45.1%
0.03%
-85.0%
Q4 2015$156,584,000
+60.8%
1,540,396
+182.2%
0.18%
+53.8%
Q3 2015$97,381,000
-18.8%
545,920
+1.1%
0.12%0.0%
Q2 2015$119,986,000
+9.0%
540,110
-2.5%
0.12%
+5.4%
Q1 2015$110,051,000
+55.0%
554,076
+11.7%
0.11%
+76.2%
Q4 2014$70,990,000
-10.0%
496,057
-17.5%
0.06%
-1.6%
Q3 2014$78,863,000
-27.5%
601,093
-30.3%
0.06%
-28.1%
Q2 2014$108,722,000
+85.9%
862,051
+94.3%
0.09%
+56.1%
Q1 2014$58,497,000
+8.3%
443,719
-3.5%
0.06%
+16.3%
Q4 2013$53,997,000459,9510.05%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2017
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders